Prestige Consumer Healthcare(PBH) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Beyond The Numbers: 4 Analysts Discuss Prestige Consumer Stock
BenzingaMar 21 17:00 ET
Correction to Premium Brands Holdings Rating
Dow JonesMar 21 13:43 ET · Ratings
CORRECTION: RBC Capital Maintains Sector Perform on Premium Brands Hldgs, Raises Price Target to C$97 (Stock Name Change From Prestige Consumer (NYSE:PBH) To (TSX: PBH) Premium Brands Holdings.
BenzingaMar 21 12:51 ET · Ratings
Express News | CORRECTION: RBC Capital Maintains Sector Perform on Premium Brands Hldgs, Raises Price Target to C$97 (Stock Name Change From Prestige Consumer (NYSE:PBH) To (TSX: PBH) Premium Brands Holdings
BenzingaMar 21 12:51 ET
Express News | RBC Capital Maintains Sector Perform on Prestige Consumer, Raises Price Target to $97
BenzingaMar 21 12:35 ET
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt
Simply Wall StMar 21 10:50 ET

Comments

Moomoo AI

Mar 26, 2024 22:08

Investors seem to focus more on the company's revenue growth despite the decrease in earnings per share. The company's long-term track record of an annual TSR of 20% over five years makes it a business worth watching.

Those Who Invested in Prestige Consumer Healthcare (NYSE:PBH) Five Years Ago Are up 144%

1

Moomoo AI

Mar 5, 2024 21:39

Investors may be expecting a turnaround in the company's lackluster revenue performance, hence the moderate P/S ratio. However, the company's muted revenue growth estimates compared to the industry make its current P/S ratio unexpected. A positive change is needed to justify this ratio.

Some Shareholders Feeling Restless Over Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Ratio

1

Moomoo AI

Feb 11, 2024 21:43

Prestige Consumer Healthcare's revenue growth is predicted to slow, with an estimated annual growth rate of 1.9% until 2025, significantly below the historical 4.2% p.a. growth. Compared to industry peers forecasted to grow at 9.0% per year, Prestige is expected to lag behind.

Here's What Analysts Are Forecasting For Prestige Consumer Healthcare Inc. (NYSE:PBH) After Its Third-Quarter Results

Moomoo AI

Jan 31, 2024 02:35

An insider selling shares below the current price may suggest they deemed the lower price fair, questioning their view of the recent higher valuation. However, this is a weak sign as it doesn't imply insiders think the shares are fully valued. The level of insider ownership indicates a reasonable alignment with shareholder interests.

This Prestige Consumer Healthcare Insider Reduced Their Stake By 57%

Moomoo Breakfast US

May 10, 2022 20:18

Columns Today's pre-market stock movers: PTON, NVAX, AMC, SONY and more

Gainers:
• $Biohaven (BHVN.US)$ +70.3% (Biohaven Pharmaceutical and Pfizer (PFE) announce that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven)
• $Vroom (VRM.US)$ +33.3% (also CEO Paul Hennessy steps down; Tom Shortt appointed as CEO)
• $Nuvve (NVVE.US)$ +10.2% (NVVE and CENN announce alliance to offer electrification solution for commercial fleets)
• $ShockWave Medical (SWAV.US)$ +14.6% (I...

20

2

3

PBH Prestige Consumer Healthcare

Trade Overview

Capital Trend

News

Comments

Market Insights

Latest News

Investment Course

Discussing

Earnings Season Underway